Abbott Laboratories: It's No Longer A Buy For Now
Abbott Laboratories is showing strong growth potential with rising sales and EPS, though slightly overvalued. See why we are ...
ETF Daily News10h
Abbott Laboratories (NYSE:ABT) Trading Up 0.6% Following Analyst Upgrade
Abbott Laboratories (NYSE:ABT – Get Free Report)’s share price was up 0.6% during mid-day trading on Friday after Sanford C. Bernstein raised their price target on the stock from $133.00 to ...
MarketWatch1d
Abbott Laboratories stock underperforms Thursday when compared to competitors despite daily gains
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Abbott Labs Path To Double-Digit Earnings Growth In 2025? This Analyst Is Optimistic
On Wednesday, Abbott Laboratories (NYSE:ABT) reported third-quarter sales of $10.64 billion, up 4.9% year over year, beating ...
Abbott Laboratories (ABT) Q3 2024 Earnings Call Transcript
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, ...
High-Quality Abbott Stock: Corporate Growth That Pays You to Own It
Abbott Laboratories is the #1 healthcare stock to own for consistent, market-beating returns over the long term. Q3 results ...
Abbott Laboratories: Balanced Prospects Lead to Hold Recommendation Amid Market Adjustments
Morgan Stanley analyst Patrick Wood maintained a Hold rating on Abbott Laboratories (ABT – Research Report) today and set a price target ...
Jim Cramer Says That FDA, NIH, and CDC Comments On Abbott Laboratories (ABT) Could Potential Help The Stock Going Forward
We recently compiled a list of the Jim Cramer is Talking About These 14 Stocks Before Earnings. In this article, we are going ...